The intimal hyperplasia hypothesis that equates lumen narrowing after arterial injury with intimal mass has recently been challenged. Evidence has emerged to suggest that lumen narrowing is caused in large part by changes in artery wall geometry rather than intimal mass per se. We have begun to explore this hypothesis in a unique nonhuman primate model of atherosclerosis. Methods: Monkeys who were fed an atherogenic diet for 3 to 5 years underwent experimental angioplasty of the left iliac artery. The contralateral iliac artery served as an intraanimal control. Arteries were removed 2, 4, 7, 14, 28, or 112 days later for analysis (6 or 13 per time point). Angioplasty dilated arteries by fracturing atheroma and stretching or tearing the media. Cross-sections of injured arteries were analyzed for expression of extracellular matrix components and cell surface integrins that are important in wound healing. Antibodies, riboprobes, or histochemical stains specific for fibrin, hyaluronan, versican (chondroitin sulfate-containing proteoglycan), procollagen-I, elastin, and the a 2 b 1 and a V b 3 integrins were used. Results: A thin mural thrombus was seen at sites of denudation and plaque fracture (days 2 to 7). This provisional matrix was invaded by leukocytes (days 2 to 4) and a-actin-positive smooth muscle cells (SMCs; days 4 to 7). Thrombus was replaced by SMCs expressing hyaluronan and the associated versican proteoglycans (day 14). Versican was expressed throughout the neointima as it enlarged (day 28), but expression later subsided (day 112). Procollagen-I expression initially increased in the adventitia (day 4) and then in the forming neointima (day 14). Procollagen-I expression was found to persist within the adventitia and in the neointima in SMCs nearest the lumen (days 28 to 112). Elastin staining was prominent within the mature neointima (day 112) but not at earlier time points. Integrin expression also increased within the injured artery wall. a v b 3 staining (fibrin[ogen] receptor) increased in the injured media (days 2 to 7) and was then seen throughout the early neointima (day 7). Low level expression of a V b 3 subsequently persisted within the forming neointima (day 28). a 2 b 1 (collagen receptor) expression increased in the neointima in SMCs nearest the lumen (day 28). Conclusions: Lumen narrowing after angioplasty in this model of atherosclerosis is caused largely by decreased artery wall diameter. The pattern of matrix and integrin expression within the injured artery wall is in many ways analogous to that of healing wounds. These observations suggest that tissue contraction may play a role in lumen narrowing at sites of arterial reconstruction. Strategies to inhibit wound contraction may prove effective in preventing restenosis. (J Vasc Surg 1998;27:96-108.)
tomatic atherosclerosis. Although an aging population and improved technology continue to broaden the application of both endovascular and surgical interventions for arterial occlusive disease, effective treatments to prevent restenosis remain elusive.
Until recently, restenosis has been viewed as the consequence of intimal hyperplasia, the accumulation of new cells and extracellular matrix (neointima) at sites of vascular injury. Neointimal mass has been equated with lumen encroachment. However, drugs that are effective at preventing intimal hyperplasia in animal models 1, 2 have consistently failed to prevent restenosis in clinical trials. 3, 4 Therefore, other, less well-defined mechanisms must play a predominant role in restenosis. The clinical application of intravascular ultrasound has allowed for serial measurement of lumen, plaque, and wall size after intervention. With this technique, it has been shown that vessel wall diameter is a major determinant of lumen caliber after angioplasty and that restenosis correlates with decreased artery wall diameter. 5 Our own data in a nonhuman primate model of atherosclerosis show that although experimental angioplasty causes significant intimal hyperplasia, lumen area does not correlate with intimal mass but rather with artery size (r = 0.72; p < 0.001). [6] [7] [8] These studies and others suggest that artery wall narrowing leads to lumen narrowing independent of the amount of intimal thickening. 9, 10 Although the cellular and molecular basis of wall narrowing after reconstruction is unknown, we suggest that parallels can be drawn to wound healing. Plaque fractures, dissections, and medial tears are wounds. In cutaneous wounds, granulation tissue forms within the coagulum as inflammatory cells and activated fibroblasts migrate into this provisional matrix. The fibroblasts then proliferate and elaborate a new collagen-rich extracellular matrix. Fibroblasts are known to differentiate into wound "myofibroblasts," which transiently express a-actin and can be stimulated to contract much like smooth muscle cells (SMCs). 11 Myofibroblasts reorganize and contract the extracellular matrix via cell surface integrins to reduce wound size. [12] [13] [14] Similarly, tissue contraction may lead to wall narrowing and restenosis as the artery wall heals.
Here we extend our observations of the structural events after injury of atherosclerotic arteries [6] [7] [8] and begin to define accompanying cellular and molecular changes that occur within the healing artery wall. The patterns of cellular ingrowth, cell surface integrin expression, and extracellular matrix elaboration are consistent with a wound healing paradigm within the artery wall. Further consideration of mechanisms of wound contraction may lead to improved outcomes after vascular reconstruction.
METHODS
Animal model. Female cynomolgus monkeys (Macaca fascicularis) involved in long-term studies of atherosclerosis at the Comparative Medicine Clinical Research Center of the Bowman Gray School of Medicine underwent experimental iliac artery angioplasty. Animals were first ovariectomized to induce a postmenopausal state and were fed an atherogenic diet for 3 to 5 years to establish complex atherosclerotic lesions. 15 Experimental angioplasty was then performed of the left common iliac artery as previously described using a 3F Fogarty catheter inflated and retrieved under tension three times. 6 The right common iliac artery served as an uninjured control vessel in each animal.
The animals were then killed 2, 4, 7, 14, 28, or 120 days after angioplasty (six each at 2, 4, 7, 14, and 120 days; 13 at 28 days). Animals were sedated with ketamine (15 mg/kg by intramuscular injection) and butorphanol (0.05 mg/kg by intramuscular injection), and were given heparin (300 U/kg by intravenous injection). Deep anesthesia was then achieved with pentobarbital (100 mg/kg by intravenous injection), and the distal abdominal aorta was cannulated. Iliac arteries were perfused in situ at physiologic pressure with lactated Ringer's until rinsed clear of blood. Half of the animals at each time-point then had both iliac arteries removed fresh, and rings cut and frozen into OCT for sectioning, with adjacent rings immersed in methyl Carnoy's fixative or 10% formalin for paraffin embedding. The other half were perfusion-fixed with 10% formalin at 100 mm Hg, and the distal aorta, iliac, and femoral arteries were removed en bloc and placed into fresh formalin overnight before paraffin embedding.
All Histologic examination. Perfusion-fixed common iliac arteries were divided into five adjacent rings for paraffin embedding. Five micrometer thick January 1998 sections were then cut from each block and stained with Verhoeff-van Gieson stain (VVG) for cross-sectional morphometry as reported previously. [6] [7] [8] Sections were also cut and stained from each of the frozen and immersion-fixed iliac artery rings. Sections were studied by light microscopy to characterize features associated with injury and healing of the vessel wall at each time point after angioplasty (e.g., plaque fracture, medial disruption, thrombus, intimal hyperplasia, and adventitial changes).
Immunohistochemical analysis. Immunohistochemical analysis was performed to determine the cellular composition and pattern of expression of various extracellular matrix molecules and cell surface integrins after experimental iliac artery angioplasty. Cross-sections from paraffin-embedded injured and uninjured iliac arteries were deparaffinized in xylenes, rehydrated in graded alcohols, and immunostained as previously described. 6, 16 For cell-type identification, antibodies specific for SMC a-actin (1:250 dilution, Boehringer), endothelial cell von Willebrand Factor (vWF; 1:500, Dako), and macrophage CD68 antigen (1:1000, Dako) were applied. For extracellular matrix, the following antibodies were used: type-I procollagen (1:10, Developmental Studies Hybridoma Bank, University of Iowa), chondroitin-6 sulfate proteoglycans (versican, 1:500, clone 3B3, Dr. Bruce Caterson), 17 and fibrin (1:100, American Diagnostica). Antibodies directed against the a v b 3 integrin dimer (1:200, clone LM609, Chemicon) 18 and the a2 integrin subunit (1:100, clone P1E6, Gibco) were applied to frozen sections postfixed in acetone. Primary antibodies were localized with appropriate biotinylated secondary antibodies and tertiary avidin-biotin-complex staining (Vector Laboratories). Control slides were stained with appropriate nonimmune immunoglobulin G in place of the primary antibody or with antibody preincu- Angioplasty fractured preexisting plaque (arrowhead) and media, with a thin mural thrombus forming at sites of injury (A, C; VVG stain). This provisional matrix was invaded by leukocytes early after injury (B; monocyte CD68 stain) and later by SMCs (D; a-actin stain). Cell proliferation was prominent at day 4 and later subsided (G; anti-BrdU stain). Subsequently, neointima (n) filled in plaque (p) fracture sites (arrows) overlying the media (m) and replaced the thrombus (E, VVG stain; and F, a-actin stain). Neointima continued to thicken to day 28 (H; VVG stain) by accumulating SMCs and matrix (I; a-actin stain). When compared with the uninjured iliac artery from the same animal (J; VVG stain), the injured adventitia (a, arrows) had thickened and fibrosed by day 28 (K; VVG stain). Original magnification: A, B, C, D, E, F, J, and K, ´200; G, ´40; and H and I, ´100.
bated with a fivefold molar excess of purified antigen. Hyaluronan was localized using a biotinylated hyaluronan-binding protein (1:20 dilution, Dr. Charles Underhill) and the avidin-biotin complex reaction as previously described. 19 Elastin was localized histochemically with an orcein stain (1% [wt/vol] in 70% acid alcohol, Harleco). Sections were counter-stained with hematoxylin and examined by light microscopy.
In situ hybridization. In situ hybridization was performed as previously described 20 using human cDNAs specific for type-I procollagen 21 and the versican core protein. 22 Briefly, formalin-fixed sections were deparaffinized in xylene, rehydrated, washed, and then incubated with proteinase K for 15 minutes at 37°C (1 mg/ml, Boehringer). Slides were then incubated in hybridization buffer for 2 hours at 37°C (0.3 mol/L NaCl; 20 mmol/L Tris, pH 7.5; 5 mmol/L ethylenediamine tetraacetic acid, 1X Denhardt solution, 10% dextran sulfate, 10 mmol/L dithiothreitol, and 50% formamide). Sense and antisense riboprobes were transcribed from each cDNA using T3 and T7 polymerases (Promega) and labeled with [35S]-UTP. Riboprobes were then applied to tissue sections overnight in hybridization buffer at 55°C. Slides were then washed and coated with autoradiographic emulsion (Kodak, NTB2), exposed for 1 and 2 weeks, developed (Kodak, D-19), and counterstained with hematoxylin. Slides were examined using dark field microscopy and differential expression of each messenger RNA determined by comparison between sense and antisenselabeled sections, as well as by contrasting the pattern of labeling between various riboprobes.
RESULTS

Structural and histologic features of injury.
Experimental angioplasty typically fractured the preexisting atherosclerotic plaque and stretched or tore the underlying media, creating a transmural artery wall injury (Fig. 1) . The subsequent healing response involved all layers of the vessel wall, with distinct responses among the preexisting atherosclerotic intima, media, and the adventitia.
Thrombus formed a provisional fibrin-rich matrix at sites of injury, which was initially populated by inflammatory cells (days 2 and 4; Fig. 1, A and B) and subsequently by a-actin-positive cells (day 7; Fig. 1, C and D) . Our previous studies have documented a brief but significant transmural wave of cell replication early after injury (days 4 and 7; Fig. 1 , G). 6 Thrombus was subsequently replaced by neointima (day 14; Fig. 1 , E through I) that filled in the plaque and medial fracture sites. The injured media repopulated rapidly with cells that expressed a-actin at day 7 and day 14. Medial fracture defects were filled in with tissue histologically indistinct from, and contiguous with, the forming neointima. The neointima thickened substantially from day 14 to 28 as a-actin-expressing cells and their extracellular matrix accumulated ( Fig. 1 , H through I). Although the size and cellular composition of the neointima were similar at days 28 and 120, the composition of the extracellular matrix In contrast, adventitial healing was distinct from the media and intima. Although hemorrhage was occasionally seen within the injured adventitia, thrombus was absent, so healing occurred within preexisting adventitial connective tissue. The typically loose extracellular matrix of the adventitia became dense and cellular when compared with uninjured arteries. Histochemical staining (VVG) demonstrated accumulation of collagen-rich matrix within the adventitia at days 14 and 28, whereas the neointima stained pale, consistent with a proteoglycan-rich matrix composition (Fig. 1, J and K) . Although others have described a clear early wave of a-actin expression by cells in the adventitia of injured arteries, 23, 24 this was not always seen in the present model. At days 4 and 7, a-actin-expressing cells (other than in microvessels) were occasionally found within the injured adventitia, but this varied greatly among injured iliac arteries. Beyond day 7, the cells that populated the interstitium of the adventitia were largely a-actin-negative fibroblasts and leukocytes.
Extracellular matrix elaboration after injury. The provisional matrix of mural thrombus at sites of injury was rich in fibrin ( Fig. 2) . As the neointima formed, fibrin was trapped between the neointima and the underlying wall components (Fig. 3 ). vWF Composite photomicrograph of iliac arteries at various times after experimental angioplasty with histologic staining above (VVG) and respective dark field images of adjacent sections labeled by in situ hybridization using a riboprobe for procollagen-I mRNA, below. Collagen expression increased within 4 days in the adventitia and then in the early neointima. Late expression is seen within the neointima near the lumen, and expression persists within the adventitia. Original magnification: control, 4, and 14 days, ´200; 28 days, ´100.
was also prominent in the platelet thrombus (Fig.  2) , and significant vWF accumulated within the extracellular matrix of the growing neointima at days 14 and 28 ( Fig. 3 ). This pattern of staining was confirmed with other antibodies to vWF and was completely inhibited by preincubating the primary antibody with a fivefold molar excess of purified human vWF (not shown). At day 120 vWF staining was decreased within the neointima.
Procollagen-I expression increased in parallel with proliferation early after angioplasty, and immunohistochemical evaluation for procollagen-I mirrored the pattern of mRNA expression (Fig. 4) . At day 4, when proliferation was maximal, expression could be seen throughout the injured adventitia. As a-actin-positive cells began to appear at day 7 and day 14, expression was seen also throughout the neointima. As the neointima thickened, procollagen-I expression localized within the neointima nearest to the lumen, a pattern that persisted at day 120. Adventitial procollagen-I expression was present throughout the period of study.
Hyaluronan and versican were not prominent in the uninjured atherosclerotic artery. These matrix molecules are important components of healing wounds, 25, 26 and their expression also increased significantly in the injured artery wall. Hyaluronan increased early within the injured media at day 4 and Composite photomicrograph of vessel cross-sections after experimental angioplasty labeled with a riboprobe specific for versican core protein mRNA. Labeling increased within the neointima at day 14 and persisted at day 28. Labeling had returned to baseline by day 120. Original magnification, ´200.
January 1998 later localized to the neointima (Fig. 5) . Hyaluronan persisted in the early neointima from day 7 to days 14, 28, and 120. Versican was also expressed early after injury. Both versican protein and mRNA were present in a pattern similar to that for hyaluronan from day 4 to 28. However, at day 120 versican core protein mRNA was no longer expressed within the healing artery wall (Fig. 6 ) and the protein staining was diminished.
As proteoglycan staining diminished late after injury, elastin fiber formation increased markedly within the neointima, as shown with orcein staining (Fig. 7) . Elastin fibers were not seen within the early neointima from days 7 to 28, but they increased substantially within the mature neointima at day 120. Elastin fibers aligned tangential to the direction of flow and were arranged loosely in layers parallel to the internal elastic lamina.
Contractile integrin expression after injury. Integrin expression was altered by injury. The a 2 (b 1 ) integrin, important in collagen-I contraction and reorganization by fibroblasts and SMCs, 11, 27, 28 was absent in the uninjured iliac artery wall, even when significant preexisting atherosclerotic plaque was present. Staining increased transiently within the neointima at day 28, where it localized to endothelial cells and SMCs closest to the lumen (Fig. 8) . This pattern mirrored that of neointimal procollagen-I expression at that time point. In contrast, the a v b 3 integrin, important in cell-matrix interactions with vitronectin, fibrin(ogen), denatured collagen, osteopontin, and vWF, 12, 29 was present in atherosclerotic plaque and increased early after injury within the damaged media, initially by cells nearest the internal elastic lamina on day 2. Staining subsequently became diffuse throughout the media on days 4 and 7 and was also localized to cells populating the early neointima on day 7 (Fig. 9) . At day 28, staining decreased in the neointima, whereas medial and adventitial staining were at baseline.
DISCUSSION
We show in this study that angioplasty of arteries with preexisting atherosclerosis created a transmural injury or wound, and the subsequent healing response involved all layers of the artery wall. A highly regulated sequence of cellular and molecular events ensued that in many ways was analogous to wound healing. Thrombus provided a provisional matrix at sites of injury for the influx of leukocytes and a-actin-positive cells. Subsequently, a distinct temporal and spatial pattern of extracellular matrix elaboration resulted in the reorganization of the thrombus into a proteoglycan-rich and hyaluronanrich neointima. As the neointima formed, fibrin and vWF were trapped within the extracellular matrix. Neointimal growth was complete 1 month after injury, but the extracellular matrix matured further with elastin fiber formation. Proteoglycan expression was decreased at 4 months. Adventitial healing was distinct from the neointima, as it occurred within existing connective tissue. It was characterized by fibrosis as adventitial fibroblasts continually expressed collagen throughout the 4 months after injury. Cell surface integrins appropriate for reorganizing and contracting type-I collagen (a 2 b 1 ) as well as fibrin, vWF, and denatured collagen (a v b 3 ) were also expressed transiently within the healing artery wall. This pattern of cellular ingrowth, matrix elaboration, and integrin expression supports a wound healing paradigm for artery wall contraction, resulting in lumen narrowing after reconstruction.
Wound healing and tissue contraction are relatively new concepts in the pathogenesis of restenosis. However, evidence is rapidly accumulating in support of the wall narrowing hypothesis. Intravascular ultrasound imaging of atherosclerotic lesions and sites of angioplasty has provided compelling evidence that loss of artery wall size, or shrinkage, accounts for 60% to 80% of recurrent lumen narrowing. 5 Further evidence comes from stent studies. Stents provide a rigid endoluminal scaffolding to prevent wall narrowing so that stent restenosis comes entirely from neointimal formation. Stents have reduced coronary restenosis 15% to 30% by preventing wall narrowing despite inducing more neointima than angioplasty alone. [30] [31] [32] As long-term sequelae of stents remain to be defined, pharmacologic "stenting" of injured arteries is a much more attractive approach for prevention of restenosis but requires new molecular targets for intervention.
Wall narrowing after arterial injury could be a result of passive "recoil" of a compliant wall and perivascular tissue, to spasm, or to chronic tissue contraction. Our previous studies in the monkey model favor the last alternative, as wall and lumen narrowing occur days or weeks after experimental angioplasty. 6 Recoil after clinical angioplasty is well defined and acute, occurring within seconds to hours of injury. 33, 34 We and others have speculated that late tissue contraction within the healing artery wall may be analogous to wound healing. In cutaneous wounds, granulation tissue contracts to decrease wound size and to facilitate reepithelialization. 35 Granulation tissue forms as leukocytes and fibroblasts migrate into the provisional matrix provided by the fibrin clot within the wound. Specialized fibroblasts, or "myofibroblasts," invade from the adjacent wound edges, then replicate and elaborate new extracellular matrix to rapidly replace the clot with new wound granulation tissue. 35 In the present study, intimal and medial wounds were created by angioplasty and were covered by a thin platelet-fibrin thrombus. This provisional fibrin matrix was rapidly invaded by leukocytes, SMCs, and possibly by myofibroblasts. Myofibroblasts transiently express a-actin and contract much like vascular SMCs. 11 Recent studies have implicated myofibroblasts of adventitial origin in neointima formation after arterial injury. 23, 24 However, a lack of specific markers to distinguish SMCs from myofibroblasts in healing arteries prevents a clear understanding of the adventitial contribution to medial and intimal wound healing. In the present study, adventitial a-actin expression was not always seen even after deep medial injury, and adventitial healing was clearly different than medial and intimal healing. Changes within the adventitia were more consistent with fibrosis (fibroblast collagen synthesis), whereas SMCs and matrix rich in hyaluronan and versican predominated at sites of medial and intimal repair. Although adventitial fibrosis has been underemphasized in experimental studies, the vascular surgeon recognizes its sequelae when dissecting the dense connective tissue that surrounds artery segments previously treated by angioplasty. The extent of adventitial fibrosis may significantly alter remodeling of the healing artery wall and contribute to wall constriction. Wound contraction is mediated by myofibroblast-extracellular matrix interactions. Cell surface integrins are highly selective receptors for specific matrix molecules, and the pattern of integrins expressed in wounds is unique. [12] [13] [14] 35 Cultured fibroblasts and SMCs have altered integrin expression and use identical integrins for migration and for specific matrix lattice reorganization. The b1 integrins are critical for migration and contraction on collagen matrixes, as blocking antibodies specific for a 2 b 1 will prevent both functions in culture. 12, 27, 28, 36 Similarly, blocking antibodies specific for the a v b 3 integrin prevent migration and contraction in fibrin gels. 13, 37 In the present study, these integrins and appropriate extracellular matrix ligands were expressed within the injured artery wall in a temporal pattern consistent with the time course of wall contraction defined in our previous studies. 6 Although we limited our analysis to the a 2 b 1 and a v b 3 integrins, other matrix receptors have also been implicated in the arterial response to injury. 27, 38 Further evidence for the role of integrins in the arterial healing response comes from in vivo studies in animals and man. Until recently, virtually all antirestenosis therapies have failed in large multicenter clinical trials. It is intriguing that the only drug that is effective in preventing early and late complications after coronary angioplasty, ReoPro, is a b3 integrin antagonist. 39, 40 ReoPro is a human chimeric Fab fragment of a monoclonal antibody developed to inhibit the platelet IIb/IIIa integrin receptor, which mediates platelet aggregation and adhesion. ReoPro also binds the SMC a v b 3 integrin with equal affinity. This observation and the longterm reduction of death, myocardial infarction, and target vessel revascularization after angioplasty has led to speculation that ReoPro may be acting directly on the artery wall. Other SMC b3 integrin antagonists have also been effective at inhibiting intimal hyperplasia in animal models. 41, 42 However, effects on artery wall contraction and lumen narrowing have not been reported. Our finding of increased expression of contractile integrins along with their specific matrix ligands within the healing media and intima further support targeting of integrins for pharmacologic "stenting" of the injured artery wall.
The abundance of versican and hyaluronan within the healing intima is consistent with new tissue formation because both are important components of healing wounds. 25, 26 Hyaluronan is a large hydrophilic polymer of repeating disaccharides commonly associated with tissue formation in embryogenesis, wound healing, and neoplasia. 26, 43, 44 Although a role is not completely defined, hyaluronan appears to provide hydrated space favorable for cell movement, invasion, and replication. Versican binds along the hyaluronan backbone to provide an ordered matrix that can function to restore a tissue's viscoelasticity. Hyaluronan has recently been shown to be prominent in the injured rat carotid artery, 19 but present transiently when compared with injured atherosclerotic monkey arteries. The presence of hyaluronan at day 120 in the present study is similar to that seen in atherectomy tissues retrieved from restenotic human coronary arteries, where hyaluronan is variably present at late times after angioplasty. 19 The ratio of hyaluronan and associated proteoglycans to structural matrix proteins (collagen and elastin) can alter the contraction of these lattices in culture. Similar interactions within the healing artery wall may influence the degree of contraction and restenosis.
The present study has largely focused on early structural events after angioplasty, but we recognize that healing may continue to change the structure of the injured artery wall for many months. For instance, we documented a change in the composition of the neointima between day 28 and day 120 after angioplasty with loss of versican and the appearance of new elastic fibers. In human beings, lumen narrowing is frequent at later times (3 to 9 months after angioplasty), supporting a role for chronic tissue contraction in restenosis. 31 This is still consistent with a wound healing mechanism. As granulation tissue is replaced by scar, a variable extent of fibrosis and remodeling continues for many months. 35 Fibrosis and tissue contraction during late scar maturation can be extensive and disfiguring. Variability in late fibrosis and remodeling within the artery wall could affect lumen narrowing months after an intervention.
CONCLUSION
A highly regulated pattern of cellular and molecular events occurs in response to injury of atherosclerotic arteries in nonhuman primates that are in many ways analogous to wound healing. Distinct differences in healing were noted in the adventitia compared with the intima and media, and adventitial fibrosis is prominent after injury. The elaboration of specific matrix molecules and their cell surface integrin-receptors supports the concept of integrinmediated matrix reorganization by SMCs and myofibroblasts. The degree of extracellular matrix reorganization could greatly influence wall contraction after injury and thereby lumen narrowing. Although these descriptive observations lend support to a wound healing hypothesis for restenosis, only carefully designed blocking experiments can prove its relevance. As specific blocking reagents have become available these studies are now possible, and pharmacologic strategies to inhibit tissue contraction may soon help to improve outcomes of vascular reconstructions.
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DISCUSSION
Dr. Howard P. Greisler (Maywood, Ill.). This is important work, this is an important model, and those are obviously beautiful pictures. I would like to congratulate Dr. Geary and his coworkers for their refreshing lucidity and for the innovative but logical approach that they're using in developing and characterizing what I think is an important animal model of peripheral artery restenosis after balloon angioplasty. I highly recommend that this manuscript be widely read. But like most good science, these studies do provide some answers, but I think they are far more important for the questions that they raise.
In broad terms, restenosis may reflect a number of things: elastic recoil, which is probably important primarily in the coronary circulation; myointimal hyperplasia; and tissue modeling and contraction. The authors have started with the clinical observation that late human coronary restenosis after angioplasty plus stent deployment probably results in as much as a 15% to 20% decrease in restenosis as compared with balloon angioplasty alone, despite the fact that the presence of the stent induces an increase in neointimal hyperplasia. So the only logical explanation of this effect is that the stent has an impact on late remodeling and perhaps wound contraction.
The major strengths of this work today are the detailed histopathologic analyses of the responses to arterial wall injury in this very unique model, the emphasis on the role of matrix remodeling and contraction, and probably most important, the appropriate refocusing of our thinking of these responses using the paradigm of wound healing. This leads to my three questions for the author.
In short form first, which mechanical aspect of the injury induces wound contraction? Which part of the arterial wall contracts? And what are the cell types and signaling processes that link the injury to the remodeling response?
As for the first question, the angioplasty model that is used creates a very complex injury involving intimal denudation, presumably medial cell necrosis and intramural inflammation, arterial wall and periadventitial stretch, arterial wall compression, and full thickness tears of the media. Have the authors used lesser injuries, for example, injuries with and without the component of overdistention to begin to discriminate between responses to different components of the injury? This may seem a little picky, but I think it's very important because we all know the complexity and lack of uniformity of the lesions that we deal with clinically, and so most likely angioplasty of clinical lesions has relatively different amounts of these different injury components.
Second, in this model which of the layers of the arterial wall showed contraction by morphometry? Was this pattern consistent? Considering the importance of the adventitia in the pathogenesis of neointimal hyperplasia in some models of stretch injury, do the authors believe that adventitial remodeling is of great pathophysiologic relevance in this model?
The morphometric data presented were somewhat surprising to me in that it suggested that there was no difference in neointimal area when comparing 28-day and 120-day explants. In our laboratory we use a canine angioplasty model, and we find a peak in neointimal thickness at 1 month, which significantly decreases at 3 months, presumably from tissue remodeling. How do the authors explain these differences in results?
Third, the authors have shown an early expression in the forming neointima of both a v b 3 and a 2 b 1 integrins, suggesting their potential role in mediating wound contraction and remodeling. But remodeling occurs at late time points. Do the authors have data that show a temporal and a spatial correlation between wound contraction and the expression of these contractile integrins? Recently, there has been clinical use of a b3 integrin subunit inhibitor, which has shown a decrease in intimal hyperplasia in animal models and also a decrease in clinical post-coronary angioplasty myocardial infarction, possibly related to a v b 3 blockade and subsequent effects either on remodeling or on vitronectin-facilitated SMC migration. Have the authors evaluated the effect of this agent on either intimal thickening or on arterial wall contraction in this model? In other words, how do you get at the issue of causality between the expression of these contractile integrins and later wound contraction?
Finally, it must be pointed out that although these studies suggest the importance of remodeling in restenosis after balloon angioplasty, restenosis also occurs after endarterectomy, vein graft and synthetic bypass grafting, and stent deployment, all techniques likely less affected by tissue remodeling.
Again, despite these questions, or perhaps because these studies have provoked these questions, I do want to strongly acknowledge the creativity of this work and the innovation of the analyses, and I commend it to the audience for reading.
Dr. Randolph L. Geary. Thank you, Dr. Greisler, for those kind and insightful comments and questions. You point out that various types of injury may invoke different responses within the injured artery wall, and this is certainly true. We use a Fogarty balloon catheter rather than a standard angioplasty catheter, and we do a three-pass withdrawal injury. As you alluded to, this likely causes shear injury and more denudation than a standard Gruentzig catheter.
We settled on this mode of injury after experimenting with Gruentzig catheters injury in the monkey model. The problem with the Gruentzig catheter is that these arteries are very small and each lumen is a different caliber, whereas Gruentzig catheters come only in fixed diameters. Also, atherosclerotic lesions vary from monkey to monkey just as in man and often are eccentric, so that a fixed dilation may only stretch the more normal artery wall. These factors contribute to variability in the injury. With a Fogarty catheter, although we cause a more severe injury, it tends to be more consistent from artery to artery, albeit a maximal injury every time.
If you compare our histologic findings with the human situation, as previously shown by Dr. Zarins and more recently in studies with intravascular ultrasound, the fractures and dissections that we create with the Fogarty catheter are very similar to the clinical situation. We have proven, at least in our hands, that the Fogarty catheter injury does not remove any of the preexisting lesion. We have studied that very carefully. But we cannot, as you point out, rule out other effects such as the longitudinal shear that is induced by withdrawing a balloon catheter under tension. So there could be mechanical aspects to this model that differ from the clinical situation.
In terms of which layer of the healing artery wall is contracting, I would be very appreciative of any suggestions about how to sort that out. The artery wall size changes, and we can measure that by tracing the external elastic lamina or the internal elastic lamina, but we cannot quantitate the contribution of each individual wall layer. For instance, medial size and preexisting plaque size do not change after angioplasty despite a decrease in artery wall size. The neointima adds to intimal mass, and although we can measure its size, we have no way of assessing its contraction over time.
The adventitia is even more difficult to quantify if you included it in measures of artery wall size because it blends into the surrounding connective tissue and has no clear outer boundary. To complicate this issue further, when a medial fracture occurs, which happens frequently, it is overlying the fracture site that the adventitia is most involved in the injury process. So thickening and fibrosis are not circumferential in every case. Your question raises a critical issue, but this is something that we just have not been able to get our hands around.
If you consider surgical procedures on arteries that have previously undergone angioplasty, you encounter a dense adventitial fibrosis around the artery that destroys January 1998 the plane of dissection that is normally present between the artery wall and surrounding tissues. I believe that this adventitial fibrosis plays a critical role in preventing the artery from enlarging to accommodate neointimal growth and may account for constriction of the artery wall analogous to wound contraction. The neointima may also contract over time as the composition of cells, extracellular matrix, and integrins could allow for "wound contraction." I didn't address this today, but our previous studies have shown that a degree of wall contraction actually occurs early, before the neointima is well formed, at 7 and 14 days. This supports an adventitial or medial process.
As far as intimal hypoplasia regressing at late times after injury, we have studied about 48 animals at the 4-month time point. Some of those were control animals, and some were involved in treatment protocols with estrogen, trying to prevent intimal hyperplasia. In general, the ratio of the neointima to the preexisting plaque did not differ significantly from what we have reported at 1 month. I don't know why, but as you point out, in models of normal arterial injury the neointima usually regresses over time. I suspect that this has to do with shear stress and related changes in artery wall diameter. Shear and other factors that lead to neointimal regression may be overcome by the effects of preexisting atherosclerosis, as in our model.
You point out that the mechanism of restenosis is not the same for stented arteries and prosthetic grafts, where intimal hyperplasia is clearly the problem. What we are attempting to model is injury as it occurs with angioplasty, endarterectomy, and perhaps atherectomy.
Lastly, you commented on the clinical studies that demonstrated improved results after coronary angioplasty in patients treated with ReoPro. We are studying ReoPro in the monkey model. ReoPro is a b3 integrin antagonist and inhibits platelet function by blocking the platelet glycoprotein IIb/IIIa integrin receptor. It has an equal affinity for artery wall b3 integrins, which has led to speculation that improved clinical results with ReoPro may be a result of an artery wall effect in addition to, or instead of, a platelet effect. Our data are just now being compiled, and I really don't have a clear answer yet whether ReoPro will work in the monkey model.
Dr. Alexander W. Clowes (Seattle, Wash.). I have just a very brief question. These are beautiful studies. We know that in small animals the healing is conducted largely by the smooth muscle cells derived from the media, yet in these complex wounds there are many sources of aactin-positive cells. What is doing the healing? Dr. Geary. That's a very good question. Dr. Wilcox at Emory has suggested that myofibroblasts, which express a-actin, are as important in repopulating the injured artery wall as smooth muscle cells. They performed pulselabeling experiments in which they administered BrdU to label proliferating cells within the first day or two after injury and found most labeled cells in the adventitia. When they looked at later time points, labeled cells had migrated into the neointima. So adventitial fibroblasts can contribute to the neointima. Dr. Zalewski's group in Philadelphia has published similar data in the pig angioplasty model, suggesting that adventitial fibroblasts differentiate into myofibroblasts, which, if you fracture the artery wall, participate in intimal hyperplasia. In the atherosclerotic monkey model it is less clear. We don't see a distinct wave of a-actin expression within the adventitia as described by other groups. We do see it occasionally, but it's far less consistent. It appears that the healing process that forms the neointima is different than the process we see in the adventitia. I will speculate that myofibroblasts are contributing more to the fibrotic response in the adventitia. We know that in culture and in models of wound healing that fibroblasts are better producers of collagen and other structural matrix molecules than smooth muscle cells, whereas in the intima it's probably predominantly a smooth muscle cell process.
